Sort
48,018 grants matching “immunotherapy”
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$546,612Nikhil Joshi · Yale University · R01 · FY2023 · CA
DNA BASED ADJUVANT IMMUNIZATION FOR HIV
$546,600University Of Pittsburgh At Pittsburgh · R01 · FY2001 · AI
Identifying antitumor T cell receptors for cellular immunotherapy
$546,592Sri Krishna · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Studying phenotypic states of antitumor human T cells
$546,592Sri Krishna · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
A novel signaling mechanism for LRP5
$546,536Dianqing Wu · Yale University · R01 · FY2025 · CA
A novel signaling mechanism for LRP5
$546,536Dianqing Wu · Yale University · R01 · FY2022 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$546,511Yina Hsing Huang · Dartmouth College · R01 · FY2024 · CA
Antibody Mediated Immune Regulation
$546,429James C. Zimring · University Of Virginia · P01 · FY2019 · HL
Boosting anti-HIV immunity through manipulation of Tfh function.
$546,312Elias K Haddad · Drexel University · R01 · FY2017 · AI
Targeting T Cells for enhancing anti-tumor immunity in pediatric brain tumors.
$546,308Anusha Preethi Ganesan · University Of California, San Diego · R37 · FY2025 · CA
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
$546,210Anna Karolina Palucka · Baylor Research Institute · R01 · FY2009 · CA
Novel molecular imaging approaches to monitor gene and cell-based therapies
$546,171Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2013 · CA
Alternative MHCII Processing of Influenza Virus Proteins
$546,128Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2017 · AI
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$546,013Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
$546,000Progenics Pharmaceuticals, Inc. · R01 · FY2001 · AI
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
$546,000Progenics Pharmaceuticals, Inc. · R01 · FY2000 · AI
Molecular basis of recognition in the Immunological Synapse
$546,000Andras Fiser · Albert Einstein College Of Medicine · R35 · FY2023 · GM
Molecular basis of recognition in the Immunological Synapse
$546,000Andras Fiser · Albert Einstein College Of Medicine · R35 · FY2022 · GM
Transcriptional and metabolic heterogeneity in T cell differentiation
$546,000Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2025 · AI
Molecular basis of recognition in the Immunological Synapse
$546,000Andras Fiser · Albert Einstein College Of Medicine · R35 · FY2024 · GM
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
$546,000Progenics Pharmaceuticals, Inc. · R01 · FY2002 · AI
Transcriptional and metabolic heterogeneity in T cell differentiation
$546,000Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2024 · AI
Molecular basis of recognition in the Immunological Synapse
$546,000Andras Fiser · Albert Einstein College Of Medicine · R35 · FY2021 · GM
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$545,997Yi Lin · Mayo Clinic Rochester · R01 · FY2017 · CA
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$545,975Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2024 · CA